Ironwood Pharmaceuticals, Inc | Ironwood Pharmaceuticals | Massachusetts | state | 2012 | $1,836,449 | | tax credit/rebate |
Biogen Idec MA, Inc | Biogen | Massachusetts | state | 2012 | $1,836,449 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc | Takeda Pharmaceutical | Massachusetts | state | 2012 | $3,000,000 | | tax credit/rebate |
Anika Therapeutics, Inc. | Anika Therapeutics | Massachusetts | state | 2012 | undisclosed | | tax credit/rebate |
Depuy Mitek, Inc. | Johnson & Johnson | Massachusetts | state | 2012 | undisclosed | | tax credit/rebate |
Depuy Spine, Inc. | Johnson & Johnson | Massachusetts | state | 2012 | undisclosed | | tax credit/rebate |
Codman and Shurtleff, Inc. | Johnson & Johnson | Massachusetts | state | 2012 | undisclosed | | tax credit/rebate |
Endo Pharmaceuticals | Endo International | Pennsylvania | state | | $462,000 | | tax credit/rebate |
Viropharma Incorporated | Takeda Pharmaceutical | Pennsylvania | state | | $453,000 | | tax credit/rebate |
Immunex Rhode Island Corp. | Amgen | Rhode Island | state | 2013 | $258,315 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2012 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2011 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2010 | $100,000 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2010 | $100,000 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2010 | $61,206 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2009 | $100,000 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2009 | $100,000 | | tax credit/rebate |
AVID Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2008 | $100,000 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2008 | $100,000 | | tax credit/rebate |
AVID Radiopharaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2007 | $100,000 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2006 | $100,000 | | tax credit/rebate |
Novo Nordisk | Novo Holdings A/S | North Carolina | state | 1992 | $141,554 | | grant |
Embrex, Inc. | Pfizer | North Carolina | state | 2003 | $65,000 | | grant |
Wyeth-Lederle (#2) | Pfizer | North Carolina | state | 2004 | $500,000 | | grant |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,800 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,293 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,200 | | cost reimbursement |
Novitas Solutions, Inc. | Novartis | Florida | state | 2013 | $500,000 | | tax credit/rebate |
Actavis, Inc. | AbbVie | Florida | state | 2013 | $690,000 | | grant |
Novitas Solutions, Inc. | Novartis | Florida | state | 2013 | $1,200,000 | | tax credit/rebate |
United Therapeutics Corporation & Subs. | United Therapeutics | Maryland | state | 2010 | $21,746 | | tax credit/rebate |
Emergent Biosolutions, Inc. & Subsidiaries | Emergent BioSolutions | Maryland | state | 2010 | $19,113 | | tax credit/rebate |
Otsuka America Inc. | Otsuka Pharmaceutical | Maryland | state | 2010 | $65,321 | | tax credit/rebate |
Sucampo Pharma Americas, Inc. | Mallinckrodt | Maryland | state | 2010 | $15,746 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2010 | $698,034 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2010 | $36,741 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2010 | $20,997 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2010 | $10,666 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2010 | $42,015 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2010 | $18,433 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2011 | $27,537 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2011 | $7,890 | | tax credit/rebate |
United Therapeutics Corporation and Subs. | United Therapeutics | Maryland | state | 2011 | $17,214 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2011 | $60,998 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Maryland | state | 2011 | $15,463 | | tax credit/rebate |
TEVA Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2011 | $26,524 | | tax credit/rebate |
Sucampo Pharma Americas, Inc. | Mallinckrodt | Maryland | state | 2011 | $37,575 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2011 | $462,285 | | tax credit/rebate |
Emergent Biosolutions Inc. & Subsidiaries | Emergent BioSolutions | Maryland | state | 2011 | $17,868 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2011 | $36,726 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2011 | $49,888 | | tax credit/rebate |
McNeil Consumer Healthcare Division of McNEll-PPC, | Johnson & Johnson | Illinois | state | 2013 | $105,502 | | tax credit/rebate |
IDEXX DISTRIBUTION INC | IDEXX Laboratories | Maine | state | 2013 | $1,515 | | property tax abatement |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2013 | $2,613 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2013 | $18,018 | | property tax abatement |
IDEXX LAB INC | IDEXX Laboratories | Maine | state | 2013 | $64,733 | | property tax abatement |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2013 | $75,901 | | property tax abatement |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Connecticut | state | 2012 | $344,500 | | tax credit/rebate |
Boehringer Ingelheim USA Corporation | Boehringer Ingelheim | Connecticut | state | 2012 | $98,000 | | tax credit/rebate |
Alexion Pharmaceuticals, Inc | AstraZeneca | Connecticut | state | 2013 | $26,000,000 | | grant/loan hybrid program |
Durata Therapeutics, Inc. | AbbVie | Connecticut | state | 2013 | $2,250,000 | | grant/loan hybrid program |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $1,050,000 | | tax credit/rebate |
MedImmune, Inc. | AstraZeneca | Maryland | state | 2004 | $26,775 | | training reimbursement |
Shire US Manufacturing, Inc. | Takeda Pharmaceutical | Maryland | state | 2004 | $26,595 | | training reimbursement |
Shire US Manufacturing, Inc. | Takeda Pharmaceutical | Maryland | state | 2008 | $24,791 | | training reimbursement |
Shire US Manufacturing Inc. | Takeda Pharmaceutical | Maryland | state | 2007 | $23,191 | | training reimbursement |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2007 | $15,373 | | training reimbursement |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2007 | $1,570,977 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2012 | $1,497,096 | | tax credit/rebate |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2005 | $728,623 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2008 | $611,575 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Maryland | state | 2004 | $588,423 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2009 | $490,223 | | tax credit/rebate |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2004 | $294,900 | | tax credit/rebate |
MacroGenics, Inc. and Subsidiaries | MacroGenics | Maryland | state | 2008 | $251,056 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2005 | $195,386 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2009 | $191,686 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | Maryland | state | 2008 | $131,514 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2008 | $126,743 | | tax credit/rebate |
Pfizer Corporation | Pfizer | Maryland | state | 2007 | $123,426 | | tax credit/rebate |
Medimmune Oncology, Inc. | AstraZeneca | Maryland | state | 2005 | $111,606 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2007 | $111,395 | | tax credit/rebate |
Medimmune Oncology, Inc. | AstraZeneca | Maryland | state | 2004 | $103,579 | | tax credit/rebate |
Emergent Biosolutions Inc. & Subsidiaries | Emergent BioSolutions | Maryland | state | 2012 | $103,503 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2007 | $100,927 | | tax credit/rebate |
Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | Maryland | state | 2008 | $96,916 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2007 | $94,861 | | tax credit/rebate |
Otsuka American Pharmaceutical, Inc. | Otsuka Pharmaceutical | Maryland | state | 2007 | $92,420 | | tax credit/rebate |
Amgen Inc. | Amgen | Maryland | state | 2004 | $88,478 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2012 | $80,651 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2008 | $76,270 | | tax credit/rebate |
Pharmacia Corporation | Pfizer | Maryland | state | 2008 | $74,621 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Maryland | state | 2012 | $74,558 | | tax credit/rebate |
Otsuka America, Inc. c/o Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | Maryland | state | 2009 | $65,411 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2008 | $64,386 | | tax credit/rebate |
Amgen Inc. | Amgen | Maryland | state | 2005 | $61,793 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2012 | $60,651 | | tax credit/rebate |
Pfizer Inc. | Pfizer | Maryland | state | 2005 | $60,097 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2012 | $59,756 | | tax credit/rebate |
Emergent Product Development Gaithersburg, Inc. (FKA Emergent InnunoSolutions, Inc.) | Emergent BioSolutions | Maryland | state | 2007 | $58,921 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | Maryland | state | 2009 | $56,291 | | tax credit/rebate |